Premier Fund Managers Ltd cut its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 124,533 shares of the company’s stock after selling 3,310 shares during the period. Premier Fund […]